Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Pfizer’s Shanghai Anti-Infectives Research Unit Delayed

publication date: Nov 15, 2011
Pfizer said it will extend the timeline on the buildout of its Shanghai Anti-Infectives Research Unit. Earlier, an internet report stated the China research program had been cancelled. In February of this year, Pfizer announced it would close its Anti-Infectives unit in Groton, Conn. and transfer the operation to Shanghai. The move was supposed to take up to two years. Now, Pfizer says the timeline is extended, though the company has not announced a new schedule. More details....

Stock Symbol: (NYSE: PFE)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital